GMAB and CORT Related Headlines

Go Back

Oct 23, 2026 12:20PM Genmab stock surges 9% following positive phase 3 ovarian cancer trial results

GMAB and CORT Related Press Releases

Go Back

GMAB and CORT Related SEC Filings

Go Back